Abstract
Atrial fibrillation (AF) is known to aggregate within family and might be associated with a lower quality-of-life (QoL). We evaluated the association between a family history (FHx) of AF and patient-reported symptom burden and perception towards treatment. We performed a retrospective analysis in a cohort of 1285 newly diagnosed patients with AF. Patients completed the atrial fibrillation effect on quality of life (AFEQT) questionnaire at the time of registration and at the 1-year follow-up. Patients who had a first-degree relative with AF were classified into the FHx group. Baseline characteristics and AFEQT scores were compared between groups, and a multivariate analysis was used to evaluate the independent association between FHx and QoL. Overall, 15.9% of patients (n = 204) had a positive AF FHx. Compared to the non-FHx group, the FHx group had an earlier onset of AF (60.2 ± 12.0 years vs. 64.5 ± 12.1 years; P < 0.05) and lower AFEQT overall summary (AFEQT-OS) score at baseline (73.9 ± 17.8 vs. 77.0 ± 16.8; P < 0.05). After adjustment for clinical background, a positive FHx was independently associated with a worse QoL (changes in AFEQT-OS score = − 3.18; 95% confidence interval: − 5.67 to − 0.69; P = 0.012). No between-group difference in AFEQT-OS scores was noted at the 1-year follow-up. An FHx of AF was associated with a lower QoL, which could be improved by therapeutic intervention in patients with AF. Recognizing the presence of an FHx of AF is important to predict patient’s symptom load and treatment acceptance.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- AFEQT:
-
Atrial fibrillation effects on quality of life
- FHx:
-
Family history
- QoL:
-
Quality of life
References
Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy DR, Wimmer AP, Bhandari A, Burk C (2011) Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 4:15–25
Lubitz SA, Yin X, Fontes JD, Magnani JW, Rienstra M, Pai M, Villalon ML, Vasan RS, Pencina MJ, Levy D, Larson MG, Ellinor PT, Benjamin EJ (2010) Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 304:2263–2269
Chang SH, Kuo CF, Chou IJ, See LC, Yu KH, Luo SF, Huang LH, Zhang W, Doherty M, Wen MS, Kuo CT, Yeh YH (2017) Association of a family history of atrial fibrillation with incidence and outcomes of atrial fibrillation: a population-based family cohort study. JAMA Cardiol 2:863–870
Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, Schlapfer J, Fischer A, Merkel T, Kuhne M, Sticherling C, Osswald S, Conen D (2017) Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation. J Am Heart Assoc 6:e005401
Golwala H, Jackson LR 2nd, Simon DN et al (2016) Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from outcomes registry for better informed treatment for atrial fibrillation registry. Am Heart J 174:29–36
Bhave PD, Lu X, Girotra S, Kamel H, Vaughan Sarrazin MS (2015) Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm 12:1406–1412
Chiang CE, Zhang S, Tse HF, Teo WS, Omar R, Sriratanasathavorn C (2013) Atrial fibrillation management in Asia: from the Asian expert forum on atrial fibrillation. Int J Cardiol 164:21–32
Inohara T, Kimura T, Ueda I, Ikemura N, Tanimoto K, Nishiyama N, Aizawa Y, Nishiyama T, Katsumata Y, Fukuda K, Takatsuki S, Kohsaka S (2017) Effect of compliance to updated AHA/ACC performance and quality measures among patients with atrial fibrillation on outcome (from Japanese multicenter registry). Am J Cardiol 120:595–600
Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Chang P, Peterson ED, Piccini JP (2015) Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes 8:393–402
Gundlund A, Fosbol EL, Kim S, Fonarow GC, Gersh BJ, Kowey PR, Hylek E, Mahaffey KW, Thomas L, Piccini JP, Peterson ED, ORBIT-AF investigators (2016) Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry. Am Heart J 175:28–35
Dewland TA, Olgin JE, Vittinghoff E, Vittinghoff E, Marcus GM (2013) Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 128:2470–2477
Kabra R, Cram P, Girotra S, Vaughan Sarrazin M (2015) Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation. Am J Cardiol 116:230–235
Gundlund A, Christiansen MN, Hansen ML, Olesen JB, Zahir D, Kober L, Gislason GH, Piccini JP, Peterson ED, Torp-Pedersen C, Fosbol EL (2016) Familial clustering and subsequent incidence of atrial fibrillation among first-degree relatives in Denmark. Europace 18:658–664
Oyen N, Ranthe MF, Carstensen L, Boyd HA, Olesen MS, Olesen SP, Wohlfahrt J, Melbye M (2012) Familial aggregation of lone atrial fibrillation in young persons. J Am Coll Cardiol 60:917–921
Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA (2005) Familial aggregation in lone atrial fibrillation. Hum Genet 118:179–184
Jurkko R, Palojoki E, Huttunen H, Holm C, Lehto M, Helio T, Swan H, Toivonen L (2013) Characteristics of atrial fibrillation and comorbidities in familial atrial fibrillation. J Cardiovasc Electrophysiol 24:768–774
Gundlund A, Olesen JB, Staerk L, Lee C, Piccini JP, Peterson ED, Kober L, Torp-Pedersen C, Gislason GH, Fosbol EL (2016) Outcomes associated with familial versus nonfamilial atrial fibrillation: a matched nationwide cohort study. J Am Heart Assoc 5:e003836
Randolph TC, Simon DN, Thomas L, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED, Piccini JP, ORBIT AF Investigators and Patients (2016) Patient factors associated with quality of life in atrial fibrillation. Am Heart J 182:135–143
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GYH, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G (2007) Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German atrial fibrillation competence NETwork and the European heart rhythm association. Europace 9:1006–1023
Banik A, Schwarzer R, Pawlowska I, Boberska M, Cieslak R, Luszczynska A (2017) Women with family cancer history are at risk for poorer physical quality of life and lower self-efficacy: a longitudinal study among men and women with non-small cell lung cancer. Health Qual Life Outcomes 15:62
Charitakis E, Barmano N, Walfridsson U, Walfridsson H (2017) Factors Predicting arrhythmia-related symptoms and health-related quality of life in patients referred for radiofrequency ablation of atrial fibrillation: an observational study (the SMURF study). JACC Clin Electrophysiol 3:494–502
Kapur S, Kumar S, John RM, Stevenson WG, Tedrow UB, Koplan BA, Epstein LM, MacRae CA, Michaud GF (2018) Family history of atrial fibrillation as a predictor of atrial substrate and arrhythmia recurrence in patients undergoing atrial fibrillation catheter ablation. Europace 20:921–928
Alzahrani Z, Ornelas-Loredo A, Darbar SD, Farooqui A, Mol D, Chalazan B, Villagrana NE, McCauley M, Lazar S, Wissner E, Bhan A, Konda S, Darbar D (2018) Association between family history and early-onset atrial fibrillation across racial and ethnic groups. JAMA Network Open 1:e182497
Weng LC, Choi SH, Klarin D, Smith JG, Loh PR, Chaffin M, Roselli C, Hulme OL, Lunetta KL, Dupuis J, Benjamin EJ, Newton-Cheh C, Kathiresan S, Ellinor PT, Lubitz SA (2017) Heritability of atrial fibrillation. Circ Cardiovasc Genet 10:e001838
Funding
This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant no. 16H05215) and by an unrestricted research grant from Bayer Yakuhin Ltd.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Kohsaka received an unrestricted research grant for the Department of Cardiology at Keio University School of Medicine from Bayer Pharmaceutical and Daichi Sankyo. Dr. Takatsuki received honoraria from Bayer Pharmaceutical, Daiichi Sankyo, Bristrol Myers Squibb and Boehringer. The authors report no other relationships that could be construed as a conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fujisawa, T., Kimura, T., Kohsaka, S. et al. Symptom burden and treatment perception in patients with atrial fibrillation, with and without a family history of atrial fibrillation. Heart Vessels 36, 267–276 (2021). https://doi.org/10.1007/s00380-020-01687-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-020-01687-w